VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia (VOCALE LBD)
Reducing Depression in Family Caregivers of Persons Living With Lewy Body Dementia Through Tailored Asynchronous Online Intervention.
This study tests whether a tailored, fully asynchronous online group intervention (VOCALE LBD) reduces depression in family caregivers of people with Lewy Body Dementia (LBD), compared to standard educational materials. LBD is the second most common form of degenerative dementia and causes distinct challenges, including visual hallucinations, REM sleep disorder, and severe motor symptoms, that are not addressed by generic caregiver interventions. Depression rates in LBD caregivers reach 40-50%, double the rate seen in Alzheimer's disease caregivers, yet no rigorous digital interventions exist specifically for this population. VOCALE LBD is a text-based, low-bandwidth platform (Discourse) that brings groups of 10-15 caregivers together in an 8-week moderated online community. Weekly topics address LBD-specific challenges (sleep problems, hallucinations, self-care) and problem-solving skills using the ADAPT method. A pilot study (n=54) showed strong effects on depressive symptoms (Cohen's d=0.54 at 1-month follow-up), near-perfect engagement, and high participant satisfaction. This RCT (N=220) will test efficacy, examine mechanisms of action (self-efficacy and problem-solving), and explore analytics approaches for pragmatic monitoring, laying groundwork for future implementation in clinics and community organizations.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Over 1.4 million people in the U.S. are diagnosed with Lewy Body Dementia (LBD). Up to 80% receive care from family members, yet family caregivers of people with LBD experience depression at rates (40-50%) double those of Alzheimer's disease caregivers. LBD's distinct features - visual hallucinations, REM sleep behavior disorder, cognitive fluctuations, and Parkinsonian motor symptoms - create caregiving demands not addressed by existing dementia caregiver interventions. Current pharmacological treatments for LBD are largely experimental, leaving families to manage severe behavioral and motor symptoms without adequate support. INTERVENTION: VOCALE LBD (Virtual Online Communities for Aging Life Experiences - Lewy Body Dementia) is a fully asynchronous, text-based online group intervention delivered via the Discourse platform. The 8-week program includes icebreaker activities followed by LBD-specific weekly topics (self-care, sleep problems, hallucinations and delusions) and problem-solving training using the ADAPT method (Adopting a positive attitude, Defining the problem, brainstorming Alternatives, Predicting consequences, Trying the solution). Groups of 10-15 caregivers are moderated by a licensed nurse or social worker (RN/LCSW), who logs in daily and facilitates discussions. The platform requires no video conferencing and is accessible via any internet-connected device. Loaner devices and digital literacy training are provided for participants who need them. STUDY DESIGN: Two-arm, randomized controlled trial. Participants are randomized 1:1 to (a) VOCALE LBD or (b) Standard of Care (SOC: NIA psychoeducational materials, LBDA resource list, problem-solving handouts). Assessment time points: baseline, post-intervention (week 8), and 6-month follow-up. Exit interviews are conducted at the end of the intervention. AIMS: Aim 1 tests whether VOCALE LBD reduces depressive symptoms (CES-D) compared to SOC at week 8, with sustained effect at 6 months. Aim 2 examines mechanisms - whether self-efficacy and problem-solving mediate outcomes (2a quantitative mediation; 2b qualitative analysis). Aim 3 explores pragmatic monitoring using user engagement analytics, natural language processing, and LLM-assisted moderator support tools. RECRUITMENT: Nationwide recruitment through the Lewy Body Dementia Association (LBDA) via eblasts, social media, support groups, and print materials. Additional outreach via Alzheimer.gov and national LBD caregiver web resources.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Oleg Zaslavsky, PhD, RN
- Numero di telefono: (206) 849-3301
- Email: zaslav@uw.edu
Backup dei contatti dello studio
- Nome: Aimy Paulsen, MPH
- Numero di telefono: (253) 693-8329
- Email: vocale-lbd@uw.edu
Luoghi di studio
-
-
Washington
-
Seattle, Washington, Stati Uniti, 98195
- Reclutamento
- University of Washington
-
Contatto:
- Oleg Zaslavsky, PhD, RN
- Numero di telefono: (206) 849-3301
- Email: zaslav@uw.edu
-
Contatto:
- Aimy Paulsen, MPH
- Numero di telefono: (253) 693-8329
- Email: vocale-lbd@uw.edu
-
Investigatore principale:
- Oleg Zaslavsky, PhD, RN
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Current family member or informal (unpaid) caregiver of a person with a confirmed diagnosis of Lewy Body Dementia (LBD) or LBD mixed pathology
- Experiences depressive symptoms as defined by a score of 5 or higher on the Patient Health Questionnaire-9 (PHQ-9)
- Able to read, write, and speak English
- Has access to a device (computer, tablet, or smartphone) that can connect to the internet and be used for videoconferencing or phone calls, OR is interested in using a loaner device
- Has an active email address OR is willing to create and use an email address prior to enrollment
Exclusion Criteria:
- Active suicidal ideation as indicated by endorsement of PHQ-9 Item 9 (thoughts that you would be better off dead, or thoughts of hurting yourself)
- Paid or professional caregiver (must be unpaid family/informal caregiver)
- Unable to read, write, or speak English
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: VOCALE LBD
Participants in this arm receive the VOCALE LBD intervention: an 8-week, fully asynchronous, text-based online group program delivered via the Discourse platform. Groups of 10-15 participants are facilitated by trained moderators who log in daily. Weekly discussion topics address LBD-specific caregiving challenges (sleep problems, hallucinations and delusions) and problem-solving skills training using the ADAPT method. Participants are asked to make a minimum of three posts each week (e.g., adding a post, replying to two other users). |
The 8-week VOCALE LBD intervention is delivered asynchronously via the Discourse online platform. The weekly curriculum includes: Pre-intervention (Icebreakers, Self-introductions); Week 1 (Sleep Problems); Week 2 (Hallucinations and Delusions); Week 3 (ADAPT - Positive Attitude); Week 4 (ADAPT - Define the Problem); Week 5 (ADAPT - Alternative Solutions); Week 6 (ADAPT - Plan); Week 7 (ADAPT - Try); Week 8 (Reflection and Wrap Up).
Altri nomi:
|
|
Comparatore attivo: Standard of Care
NIA and LBDA psychoeducational materials on LBD and caregiving; LBDA resource list; problem-solving principles handout. Materials delivered via email. |
NIA and LBDA psychoeducational materials on LBD and caregiving; LBDA resource list; problem-solving principles handout. Materials delivered via email or mail per participant preference. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Center for Epidemiologic Studies Depression Scale (CES-D)
Lasso di tempo: Baseline (pre-randomization), Post-intervention (Week 8), 6-month follow-up
|
The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report questionnaire that evaluates the frequency of depressive symptoms experienced in the past week (including depressed mood, feelings of guilt/worthlessness, helplessness, and physical symptoms). Total scores range from 0 to 60. Higher scores indicate greater severity of depressive symptoms (worse outcome). |
Baseline (pre-randomization), Post-intervention (Week 8), 6-month follow-up
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Short Zarit Caregiver Burden Interview (ZBI-12)
Lasso di tempo: Baseline, Week 8, 6-month follow-up
|
The Short Zarit Caregiver Burden Interview (ZBI-12) is a 12-item self-report instrument that measures personal strain and role strain associated with caregiving. Total scores range from 0 to 48. Higher scores indicate greater caregiver burden (worse outcome). |
Baseline, Week 8, 6-month follow-up
|
|
UCLA Loneliness Scale (3-Item Short Form)
Lasso di tempo: Baseline, Week 8, 6-month follow-up
|
The UCLA Loneliness Scale (3-Item Short Form) is a 3-item self-report survey assessing subjective feelings of loneliness and social isolation. Total scores range from 3 to 9. Higher scores indicate greater loneliness and social isolation (worse outcome). |
Baseline, Week 8, 6-month follow-up
|
|
Perceived Stress Scale (PSS-10)
Lasso di tempo: Baseline, Week 8, 6-month follow-up
|
The Perceived Stress Scale (PSS-10) is a 10-item instrument measuring an individual's perception of stress and feelings of unpredictability, uncontrollability, and overload during the past month. Total scores range from 0 to 40. Higher scores indicate greater perceived stress (worse outcome). |
Baseline, Week 8, 6-month follow-up
|
|
Medical Outcomes Study Social Support Survey (MOS-SSS)
Lasso di tempo: Baseline, Week 5 (mid-intervention), Week 8, 6-month follow-up
|
The Medical Outcomes Study Social Support Survey (MOS-SSS) is a 19-item questionnaire evaluating multiple dimensions of social support (emotional/informational, tangible, affectionate, and positive social interaction). Raw total scores range from 19 to 95 (which can be transformed to an overall index score of 0 to 100). Higher scores indicate greater social support (better outcome). |
Baseline, Week 5 (mid-intervention), Week 8, 6-month follow-up
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Social Problem-Solving Inventory-Revised (SPSI-R Short Form)
Lasso di tempo: Baseline, Week 5, Week 8, 6-month follow-up
|
The Social Problem-Solving Inventory-Revised (SPSI-R:S) is a 25-item self-report instrument assessing cognitive and behavioral problem-solving orientations and skills across five subscales (Positive Problem Orientation, Negative Problem Orientation, Rational Problem Solving, Impulsivity/Carelessness Style, and Avoidance Style). Standardized total scores range from 0 to 20. Higher total scores indicate better social problem-solving skills (better outcome). Used as mechanistic measure. |
Baseline, Week 5, Week 8, 6-month follow-up
|
|
General Self-Efficacy Scale (GSE)
Lasso di tempo: Baseline, Week 5, Week 8, 6-month follow-up
|
The General Self-Efficacy Scale (GSE) is a 10-item self-report questionnaire assessing optimistic self-beliefs and confidence in coping with daily difficulties and novel situations. Total scores range from 10 to 40. Higher scores indicate greater general self-efficacy (better outcome). |
Baseline, Week 5, Week 8, 6-month follow-up
|
|
Caregiver Self-Efficacy Scale (CSES-8)
Lasso di tempo: Baseline, Week 5, Week 8, 6-month follow-up
|
The Caregiver Self-Efficacy Scale is an 8-item self-report questionnaire measuring caregiver confidence in managing caregiving demands, obtaining respite, and handling challenging behaviors. Total scores range from 0 to 100 (percent confidence). Higher scores indicate greater caregiver self-efficacy (better outcome). |
Baseline, Week 5, Week 8, 6-month follow-up
|
|
User Engagement Scale (UES)
Lasso di tempo: Week 8
|
The User Engagement Scale (UES) is a 31-item self-report survey characterizing the depth and quality of participant interactions with the online discussion platform across four subdomains (focused attention, perceived usability, aesthetic appeal, and reward). Mean item scores range from 1 to 5. Higher scores indicate greater platform engagement (better outcome). |
Week 8
|
|
Benefits of Participating Scale
Lasso di tempo: Week 8, 6-month follow-up
|
The Benefits of Participating Scale is a 4-item questionnaire evaluating perceived personal benefit and satisfaction with program participation (rated on a 3-point scale: 1 = Not at all, 2 = Some, 3 = A great deal). Total scores range from 4 to 12. Higher scores indicate greater perceived benefit and study satisfaction (better outcome). |
Week 8, 6-month follow-up
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Investigatore principale: Oleg Zaslavsky, PhD, RN, University of Washington, School of Nursing
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Sinucleinopatie
- Malattie del cervello
- Malattie del sistema nervoso centrale
- Malattie del sistema nervoso
- Disordini mentali
- Sintomi comportamentali
- Disturbi neurocognitivi
- Demenza
- Malattie Neurodegenerative
- Disturbi del movimento
- Stress, Psicologico
- Malattie parkinsoniane
- Malattie dei gangli basali
- Comportamento
- Onere del caregiver
- Malattia del corpo di Lewy
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- STUDY00024227
- 1R01MH139601-01A1 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
De-identified individual participant data that underlie the results reported in publications (text, tables, figures, appendices) will be shared. Data will be made available 9 months following publication of the primary study results. Data will be deposited in an NIH-designated repository (e.g., NIMH Data Archive or ICPSR). Requests for data should include a data analysis plan and be submitted to the PI.
Periodo di condivisione IPD
Beginning 9 months after publication of primary outcome results; available for 5 years.
Criteri di accesso alla condivisione IPD
Researchers who provide a methodologically sound data analysis plan. Proposals should be directed to zaslav@uw.edu. To gain access, data requestors will need to sign a data access agreement.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
- ICF
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .